Abstract
Mammalian carbonic anhydrase (α-CA) gene family comprises sixteen isoforms, thirteen of which are active isozymes and three isoforms lack classical CA activity of reversible hydration of CO2 due to absence of one or more histidine residues required for CA catalytic activity. The inactive isoforms are known as carbonic anhydrase related proteins (CARPs) VIII, X and XI. Among these three, CARP VIII was reported first in 1990 from a mouse brain cDNA library and is well studied structurally as well as functionally compared to CARP X and XI. CARP VIII is an intriguing protein and is widely distributed and evolutionarily well-conserved across the species. It is mainly expressed in the Purkinje cells of cerebellum and in wide variety of other tissues both in mouse and human. CARP VIII has been linked to development of colorectal and lung cancers in humans, and overexpression of CARP VIII has been observed in several other cancers. A mutation in the CA8 gene has been associated with ataxia, mild mental retardation and quadrupedal gait in humans and with lifelong gait disorder in mice, suggesting an important role for CARP VIII in the brain. However, the precise function of CARP VIII is still an enigma. The present review article describes the previous data on CARP VIII, including its structure, role in neurodegeneration and cancer; and bioinformatic and expression analyses recently performed in our laboratory.
Keywords: Carbonic anhydrase related proteins, carbonic anhydrases, phylogenetics, structure, expression, neurodegeneration, cancer, Mammalian carbonic anhydrase (1-CA), isozymes, Purkinje cells, cerebellum, ataxia, quadrupedal gait, bioinformatic, fluorescence, chromosome, glutathione-S-transferase fusion protein (GST-HCARP VIII), higher molecular weight, SDS-PAGE, guanidine hydrochloride (GuHCl), Strongylocentrotus, Paracentrotus lividus, phylogenetic tree, animal taxonomy, orthologs, protostomes, isoleucines, inositol 1,4,5-trisphosphate (IP3), receptor type 1 (IP3R1), Ca2+ signaling, synapse recycling, proliferation, fertilization, synaptogenesis, colon cancers, neoplastic cells, malignant neoplasms, proapoptotic signals, adenoma specimens, adenocarcinomas, Paraneoplastic syndrome, breast carcinomas, paraneoplastic cerebellar degeneration (PCD), single nucleotide polymorphisms (SNPs), bone mineral density (BMD)
Current Pharmaceutical Design
Title: Carbonic Anhydrase Related Protein VIII and its Role in Neurodegeneration and Cancer
Volume: 16 Issue: 29
Author(s): Ashok Aspatwar, Martti E.E. Tolvanen, Csaba Ortutay and Seppo Parkkila
Affiliation:
Keywords: Carbonic anhydrase related proteins, carbonic anhydrases, phylogenetics, structure, expression, neurodegeneration, cancer, Mammalian carbonic anhydrase (1-CA), isozymes, Purkinje cells, cerebellum, ataxia, quadrupedal gait, bioinformatic, fluorescence, chromosome, glutathione-S-transferase fusion protein (GST-HCARP VIII), higher molecular weight, SDS-PAGE, guanidine hydrochloride (GuHCl), Strongylocentrotus, Paracentrotus lividus, phylogenetic tree, animal taxonomy, orthologs, protostomes, isoleucines, inositol 1,4,5-trisphosphate (IP3), receptor type 1 (IP3R1), Ca2+ signaling, synapse recycling, proliferation, fertilization, synaptogenesis, colon cancers, neoplastic cells, malignant neoplasms, proapoptotic signals, adenoma specimens, adenocarcinomas, Paraneoplastic syndrome, breast carcinomas, paraneoplastic cerebellar degeneration (PCD), single nucleotide polymorphisms (SNPs), bone mineral density (BMD)
Abstract: Mammalian carbonic anhydrase (α-CA) gene family comprises sixteen isoforms, thirteen of which are active isozymes and three isoforms lack classical CA activity of reversible hydration of CO2 due to absence of one or more histidine residues required for CA catalytic activity. The inactive isoforms are known as carbonic anhydrase related proteins (CARPs) VIII, X and XI. Among these three, CARP VIII was reported first in 1990 from a mouse brain cDNA library and is well studied structurally as well as functionally compared to CARP X and XI. CARP VIII is an intriguing protein and is widely distributed and evolutionarily well-conserved across the species. It is mainly expressed in the Purkinje cells of cerebellum and in wide variety of other tissues both in mouse and human. CARP VIII has been linked to development of colorectal and lung cancers in humans, and overexpression of CARP VIII has been observed in several other cancers. A mutation in the CA8 gene has been associated with ataxia, mild mental retardation and quadrupedal gait in humans and with lifelong gait disorder in mice, suggesting an important role for CARP VIII in the brain. However, the precise function of CARP VIII is still an enigma. The present review article describes the previous data on CARP VIII, including its structure, role in neurodegeneration and cancer; and bioinformatic and expression analyses recently performed in our laboratory.
Export Options
About this article
Cite this article as:
Aspatwar Ashok, E.E. Tolvanen Martti, Ortutay Csaba and Parkkila Seppo, Carbonic Anhydrase Related Protein VIII and its Role in Neurodegeneration and Cancer, Current Pharmaceutical Design 2010; 16 (29) . https://dx.doi.org/10.2174/138161210793429823
DOI https://dx.doi.org/10.2174/138161210793429823 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Impact of Genetic Variability in Nicotinic Acetylcholine Receptors on Nicotine Addiction and Smoking Cessation Treatment
Current Medicinal Chemistry Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells
Current Medicinal Chemistry Identification of VEGFR2-Binding Peptides Using High Throughput Bacterial Display Methods and Functional Assessment
Current Cancer Drug Targets Caspases: Structure-Guided Design of Drugs to Control Cell Death
Mini-Reviews in Medicinal Chemistry A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Current Pharmaceutical Design Regulatory Roles of the Ubiquitin-Proteasome System in Cardiomyocyte Apoptosis
Current Molecular Medicine Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Thrombomodulin Links Coagulation to Inflammation and Immunity
Current Drug Targets MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Mini-Review: Bmx Kinase Inhibitors for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Editorial [Hot topic:Utilizing Chinese Medicines to Improve Cancer Therapy - Fiction or Reality?(Guest Editors: Ying Huang and Moses Sing Sum Chow)]
Current Drug Discovery Technologies Neuro-endocrine Markers in Neoplasms. Diagnostic Interest and Future Prospects
Current Proteomics Bronchomediastinal Fistula with Spontaneous Resolution in a Patient with Lung Cancer
Current Respiratory Medicine Reviews Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews Phosphorothioate-Stimulated Uptake of siRNA by Mammalian Cells: A Novel Route for Delivery
Current Topics in Medicinal Chemistry Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets The Novel VEGF<sub>121</sub>-VEGF<sub>165</sub> Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF<sub>165</sub>/Lon Signaling Through PI3K-AKT-mTOR Pathway
Current Cancer Drug Targets Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry